These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11402945)

  • 1. [Implantable defibrillators. Role of the defibrillator in treatment and prevention of sudden death].
    Lellouche D; Pujadas-Berthault P; Elbaz N
    Presse Med; 2001 May 5-12; 30(17):871-3. PubMed ID: 11402945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Implantable defibrillators. Sudden death: high risk].
    Lellouche D; Pujadas-Berthault P; Elbaz N
    Presse Med; 2001 May 5-12; 30(17):867-70. PubMed ID: 11402944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
    Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P
    N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sudden cardiac death: who benefits from an implantable defibrillator?].
    Sticherling C
    Praxis (Bern 1994); 2005 May; 94(21):869-73. PubMed ID: 15966486
    [No Abstract]   [Full Text] [Related]  

  • 6. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Implantable defibrillators--current status of guidelines. Recognized and possible indications--prerequisites].
    Andresen D
    Fortschr Med; 1996 Apr; 114(11):128-32. PubMed ID: 8682425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk stratification for sudden cardiac death in post-infarct patients and in patients with dilated cardiomyopathy].
    Grimm W
    Z Kardiol; 2000; 89 Suppl 10():11-9; discussion 19-20. PubMed ID: 11151769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strain echocardiography improves risk prediction of ventricular arrhythmias after myocardial infarction.
    Haugaa KH; Grenne BL; Eek CH; Ersbøll M; Valeur N; Svendsen JH; Florian A; Sjøli B; Brunvand H; Køber L; Voigt JU; Desmet W; Smiseth OA; Edvardsen T
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):841-50. PubMed ID: 23850251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypertrophic cardiomyopathy and sudden cardiac death--ICD indications in the margin of uncertainty].
    Fauchère I; Duru F
    Praxis (Bern 1994); 2009 Aug; 98(17):941-52. PubMed ID: 19711287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of prophylactic implantable cardioverter defibrillators to prevent sudden cardiac death.
    Talajic M; Mitchell LB; Hadjis T
    Can J Cardiol; 2000 Jun; 16 Suppl C():26C-8C. PubMed ID: 10887275
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation.
    Gatzoulis KA; Vouliotis AI; Tsiachris D; Salourou M; Archontakis S; Dilaveris P; Gialernios T; Arsenos P; Karystinos G; Sideris S; Kallikazaros I; Stefanadis C
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):504-12. PubMed ID: 23588627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity as a risk factor for sustained ventricular tachyarrhythmias in MADIT II patients.
    Pietrasik G; Goldenberg I; McNitt S; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2007 Feb; 18(2):181-4. PubMed ID: 17338766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Indications for implantable cardioverter-defibrillator].
    Tebbenjohanns J; Niehaus M; Korte T
    Dtsch Med Wochenschr; 2002 Oct; 127(41):2120-4. PubMed ID: 12397558
    [No Abstract]   [Full Text] [Related]  

  • 15. [The implantable cardioverter/defibrillator].
    Kuck KH; Siebels J; Schlüter M; Meinertz T
    Herz; 1994 Oct; 19(5):287-93. PubMed ID: 8001901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epileptic patients who survived sudden cardiac death have increased risk of recurrent arrhythmias and death.
    Badheka A; Rathod A; Kizilbash MA; Lai Z; Mohamad T; Shah A; Afonso L; Jacob S
    J Cardiovasc Med (Hagerstown); 2010 Nov; 11(11):810-4. PubMed ID: 20543707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term arrhythmia-free survival in patients with severe left ventricular dysfunction and no inducible ventricular tachycardia after myocardial infarction.
    Zaman S; Narayan A; Thiagalingam A; Sivagangabalan G; Thomas S; Ross DL; Kovoor P
    Circulation; 2014 Feb; 129(8):848-54. PubMed ID: 24381209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indications and contraindications for therapy with implantable cardioverters/defibrillators].
    Neuzner J; Pitschner HF; Schlepper M
    Herz; 1994 Oct; 19(5):278-86. PubMed ID: 8001900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of ventricular tachyarrhythmias occurring in ischemic versus nonischemic patients implanted with a biventricular cardioverter-defibrillator for primary or secondary prevention of sudden death.
    Boriani G; Gasparini M; Lunati M; Santini M; Landolina M; Vincenti A; Curnis A; Bocchiardo M; Padeletti L; Biffi M; Allaria L; Denaro A;
    Am Heart J; 2006 Sep; 152(3):527.e1-11. PubMed ID: 16923425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.